The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain
Abstract
Atomic resolution characterization of the full-length p53 tetramer has been hampered by its size and the presence of extensive intrinsically disordered regions at both the N and C termini. As a consequence, the structural characteristics and dynamics of the disordered regions are poorly understood within the context of the intact p53 tetramer. Here we apply trans -intein splicing to generate segmentally 15 N-labeled full-length p53 constructs in which only the resonances of the N-terminal transactivation domain (NTAD) are visible in NMR spectra, allowing us to observe this region of p53 with unprecedented detail within the tetramer. The N-terminal region is dynamically disordered in the full-length p53 tetramer, fluctuating between states in which it is free and fully exposed to solvent and states in which it makes transient contacts with the DNA-binding domain (DBD). Chemical-shift changes and paramagnetic spin-labeling experiments reveal that the amphipathic AD1 and AD2 motifs of the NTAD interact with the DNA-binding surface of the DBD through primarily electrostatic interactions. Importantly, this interaction inhibits binding of nonspecific DNA to the DBD while having no effect on binding to a specific p53 recognition element. We conclude that the NTAD:DBD interaction functions to enhance selectivity toward target genes by inhibiting binding to nonspecific sites in genomic DNA. This work provides some of the highest-resolution data on the disordered N terminus of the nearly 180-kDa full-length p53 tetramer and demonstrates a regulatory mechanism by which the N terminus of p53 transiently interacts with the DBD to enhance target site discrimination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of the DBDs to non-specific DNA, but not to cognate recognition elements, is autoinhibited by dynamic intramolecular interactions between the N-terminal activation domain (NTAD) and the DNA binding surface (Figure 8A).41,72,73”
From Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR (2022) · cites this paper as [41]
In the citing paper
“The N-terminal region of p53 contains a highly acidic, intrinsically disordered TAD and a proline-rich region.263”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [263]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain
Wells, M., Tidow, H., Rutherford, T. J., Markwick, P., Jensen, M. R., Mylonas, E., Svergun, D. I., Blackledge, M., & Fersht, A. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801353105 · Cited by 434
The client protein p53 adopts a molten globule–like state in the presence of Hsp90
Park, S. J., Borin, B. N., Martinez-Yamout, M. A., & Dyson, H. J. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2045 · Cited by 128
Self-citationCore domain interactions in full-length p53 in solution
Veprintsev, D. B., Freund, S. M. V., Andreeva, A., Rutledge, S. E., Tidow, H., Cañadillas, J. M. P., Blair, C. M., & Fersht, A. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511130103 · Cited by 95
Research works printed but not linked: 74
- A Ayed, , Latent and active p53 are identical in conformation. Nat Struct Biol 8, 756–760 (2001). · DOI
- R Dawson, , The N-terminal domain of p53 is natively unfolded. J Mol Biol 332, 1131–1141 (2003). · DOI · Paper page
- R Candau, , Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene 15, 807–816 (1997). · DOI · Paper page
- H Lee, , Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem 275, 29426–29432 (2000). · DOI · Paper page
- N Raj, LD Attardi, The transactivation domains of the p53 protein. Cold Spring Harb Perspect Med 7, a026047 (2017). · DOI · Paper page
- O Schon, A Friedler, M Bycroft, SM Freund, AR Fersht, Molecular mechanism of the interaction between MDM2 and p53. J Mol Biol 323, 491–501 (2002). · DOI · Paper page
- W Gu, XL Shi, RG Roeder, Synergistic activation of transcription by CBP and p53. Nature 387, 819–823 (1997). · DOI · Paper page
- NL Lill, SR Grossman, D Ginsberg, J DeCaprio, DM Livingston, Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823–827 (1997). · DOI · Paper page
- JM Espinosa, RE Verdun, BM Emerson, p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell 12, 1015–1027 (2003). · DOI · Paper page
- E Appella, CW Anderson, Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268, 2764–2772 (2001). · DOI · Paper page
- Y Xu, Regulation of p53 responses by post-translational modifications. Cell Death Differ 10, 400–403 (2003). · DOI · Paper page
- CW Lee, JC Ferreon, AC Ferreon, M Arai, PE Wright, Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc Natl Acad Sci USA 107, 19290–19295 (2010). · DOI · Paper page
- DP Teufel, M Bycroft, AR Fersht, Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2. Oncogene 28, 2112–2118 (2009). · DOI · Paper page
- K Sakaguchi, , Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem 275, 9278–9283 (2000). · DOI · Paper page
- N Dumaz, DW Meek, Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18, 7002–7010 (1999). · DOI · Paper page
- PF Lambert, F Kashanchi, MF Radonovich, R Shiekhattar, JN Brady, Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem 273, 33048–33053 (1998). · DOI · Paper page
- S Rajagopalan, A Andreeva, DP Teufel, SM Freund, AR Fersht, Interaction between the transactivation domain of p53 and PC4 exemplifies acidic activation domains as single-stranded DNA mimics. J Biol Chem 284, 21728–21737 (2009). · DOI
- AS Krois, JC Ferreon, MA Martinez-Yamout, HJ Dyson, PE Wright, Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein. Proc Natl Acad Sci USA 113, E1853–E1862 (2016). · DOI · Paper page
- E Bochkareva, , Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A. Proc Natl Acad Sci USA 102, 15412–15417 (2005). · DOI · Paper page
- P Di Lello, , Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell 22, 731–740 (2006). · DOI · Paper page
- H Feng, , Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure 17, 202–210 (2009). · DOI
- LM Miller Jenkins, , Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex. Biochemistry 54, 2001–2010 (2015). · DOI
- H Tidow, , Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc Natl Acad Sci USA 104, 12324–12329 (2007). · DOI · Paper page
- AC Joerger, AR Fersht, Structural biology of the tumor suppressor p53. Annu Rev Biochem 77, 557–582 (2008). · DOI · Paper page
- F Huang, , Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer. Proc Natl Acad Sci USA 106, 20758–20763 (2009). · DOI · Paper page
- C Cain, S Miller, J Ahn, C Prives, The N terminus of p53 regulates its dissociation from DNA. J Biol Chem 275, 39944–39953 (2000). · DOI
- S Hansen, DP Lane, CA Midgley, The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability. J Mol Biol 275, 575–588 (1998). · DOI
- P Friedlander, Y Legros, T Soussi, C Prives, Regulation of mutant p53 temperature-sensitive DNA binding. J Biol Chem 271, 25468–25478 (1996). · DOI
- S Hansen, TR Hupp, DP Lane, Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. J Biol Chem; CRC Cell Transformation Group 271, 3917–3924 (1996). · DOI
- Y Wu, , Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response. Mol Cell 53, 63–74 (2014). · DOI
- AL Okorokov, , The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity. EMBO J 25, 5191–5200 (2006). · DOI · Paper page
- AC Joerger, AR Fersht, The tumor suppressor p53: From structures to drug discovery. Cold Spring Harb Perspect Biol 2, a000919 (2010). · DOI · Paper page
- M Bista, SM Freund, AR Fersht, Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy. Proc Natl Acad Sci USA 109, 15752–15756 (2012). · DOI
- C Arlt, CH Ihling, A Sinz, Structure of full-length p53 tumor suppressor probed by chemical cross-linking and mass spectrometry. Proteomics 15, 2746–2755 (2015). · DOI
- M Retzlaff, , The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain. J Mol Biol 425, 144–155 (2013). · DOI
- M D’Abramo, , The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain. Oncogene 35, 3272–3281 (2016). · DOI · Paper page
- Ö Demir, PU Ieong, RE Amaro, Full-length p53 tetramer bound to DNA and its quaternary dynamics. Oncogene 36, 1451–1460 (2017). · DOI · Paper page
- G Chillemi, , Molecular dynamics of the full-length p53 monomer. Cell Cycle 12, 3098–3108 (2013). · DOI · Paper page
- H Iwai, S Züger, J Jin, PH Tam, Highly efficient protein trans-splicing by a naturally split DnaE intein from Nostoc punctiforme. FEBS Lett 580, 1853–1858 (2006). · DOI · Paper page
- AS Aranko, S Züger, E Buchinger, H Iwaï, In vivo and in vitro protein ligation by naturally occurring and engineered split DnaE inteins. PLoS One 4, e5185 (2009). · DOI
- PV Nikolova, J Henckel, DP Lane, AR Fersht, Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. Proc Natl Acad Sci USA 95, 14675–14680 (1998). · DOI · Paper page
- AC Joerger, MD Allen, AR Fersht, Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations. J Biol Chem 279, 1291–1296 (2004). · DOI · Paper page
- TR Butt, SC Edavettal, JP Hall, MR Mattern, SUMO fusion technology for difficult-to-express proteins. Protein Expr Purif 43, 1–9 (2005). · DOI · Paper page
- J Zettler, V Schütz, HD Mootz, The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction. FEBS Lett 583, 909–914 (2009). · DOI · Paper page
- JC Ferreon, , Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc Natl Acad Sci USA 106, 6591–6596 (2009). · DOI · Paper page
- DP Teufel, SM Freund, M Bycroft, AR Fersht, Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci USA 104, 7009–7014 (2007). · DOI · Paper page
- RL Weinberg, DB Veprintsev, AR Fersht, Cooperative binding of tetrameric p53 to DNA. J Mol Biol 341, 1145–1159 (2004). · DOI · Paper page
- TJ Petty, , An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity. EMBO J 30, 2167–2176 (2011). · DOI · Paper page
- W Lee, , Solution structure of the tetrameric minimum transforming domain of p53. Nat Struct Biol 1, 877–890 (1994). · DOI · Paper page
- HW Stürzbecher, , A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7, 1513–1523 (1992).
- K McKinney, C Prives, Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein. Mol Cell Biol 22, 6797–6808 (2002). · DOI
- S Rajagopalan, F Huang, AR Fersht, Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53. Nucleic Acids Res 39, 2294–2303 (2011). · DOI · Paper page
- E Arbely, , Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration. Proc Natl Acad Sci USA 108, 8251–8256 (2011). · DOI
- G Liu, T Xia, X Chen, The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein. J Biol Chem 278, 17557–17565 (2003). · DOI
- DF Lowry, A Stancik, RM Shrestha, GW Daughdrill, Modeling the accessible conformations of the intrinsically unstructured transactivation domain of p53. Proteins 71, 587–598 (2008). · DOI
- Y Minato, T Ueda, A Machiyama, I Shimada, H Iwaï, Segmental isotopic labeling of a 140 kDa dimeric multi-domain protein CheA from Escherichia coli by expressed protein ligation and protein trans-splicing. J Biomol NMR 53, 191–207 (2012). · doi:10.1007/s10858-012-9628-3
- Y Nabeshima, M Mizuguchi, A Kajiyama, H Okazawa, Segmental isotope-labeling of the intrinsically disordered protein PQBP1. FEBS Lett 588, 4583–4589 (2014). · DOI
- S Mujtaba, , Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell 13, 251–263 (2004). · DOI · Paper page
- RR Rustandi, DM Baldisseri, DJ Weber, Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat Struct Biol 7, 570–574 (2000). · DOI
- M Arai, JC Ferreon, PE Wright, Quantitative analysis of multisite protein-ligand interactions by NMR: Binding of intrinsically disordered p53 transactivation subdomains with the TAZ2 domain of CBP. J Am Chem Soc 134, 3792–3803 (2012). · DOI
- W Borcherds, , Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells. Nat Chem Biol 10, 1000–1002 (2014). · DOI · Paper page
- PH von Hippel, OG Berg, On the specificity of DNA-protein interactions. Proc Natl Acad Sci USA 83, 1608–1612 (1986). · DOI · Paper page
- RL Weinberg, SM Freund, DB Veprintsev, M Bycroft, AR Fersht, Regulation of DNA binding of p53 by its C-terminal domain. J Mol Biol 342, 801–811 (2004). · DOI · Paper page
- K McKinney, M Mattia, V Gottifredi, C Prives, p53 linear diffusion along DNA requires its C terminus. Mol Cell 16, 413–424 (2004). · DOI · Paper page
- A Tafvizi, F Huang, AR Fersht, LA Mirny, AM van Oijen, A single-molecule characterization of p53 search on DNA. Proc Natl Acad Sci USA 108, 563–568 (2011). · DOI · Paper page
- H Kim, , p53 requires an intact C-terminal domain for DNA binding and transactivation. J Mol Biol 415, 843–854 (2012). · DOI · Paper page
- O Laptenko, , The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain. Mol Cell 57, 1034–1046 (2015). · DOI · Paper page
- W Gu, RG Roeder, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595–606 (1997). · DOI · Paper page
- J Luo, , Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 101, 2259–2264 (2004). · DOI · Paper page
- D Dornan, H Shimizu, ND Perkins, TR Hupp, DNA-dependent acetylation of p53 by the transcription coactivator p300. J Biol Chem 278, 13431–13441 (2003). · DOI
- L Müller, Sensitivity enhanced detection of weak nuclei using hetero-nuclear multiple quantum coherence. J Am Chem Soc 101, 4481–4484 (1979). · doi:10.1021/ja00510a007
- KF Morris, CS Johnson, Diffusion-ordered two-dimensional nuclear magnetic resonance spectroscopy. J Am Chem Soc 114, 3139–3141 (1992). · DOI
- Y Wang, JF Schwedes, D Parks, K Mann, P Tegtmeyer, Interaction of p53 with its consensus DNA-binding site. Mol Cell Biol 15, 2157–2165 (1995). · DOI
- M Wittekind, L Mueller, HNCACB, a high-sensitivity 3D NMR experiment to correlate amide-proton and nitrogen resonances with the alpha- and beta-carbon resonances in proteins. J Magn Reson 101, 201–205 (1993). · DOI · Paper page
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Lambourne, L., Mattioli, K., Santoso, C., Sheynkman, G., Inukai, S., Kaundal, B., Berenson, A., Spirohn-Fitzgerald, K., Bhattacharjee, A., Rothman, E., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.03.004 · Cited by 42
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Baughman, H. E. R., Narang, D., Chen, W., Villagrán Suárez, A. C., Lee, J., Bachochin, M. J., Gunther, T. R., Wolynes, P. G., & Komives, E. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102349 · Cited by 27
Waszkiewicz, R., Michaś, A., Białobrzewski, M. K., Klepka, B. P., Cieplak-Rotowska, M. K., Staszałek, Z., Cichocki, B., Lisicki, M., Szymczak, P., & Niedzwiecka, A. (2024) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.4c00312 · Cited by 16
Metadata
- Authors
- Krois, A. S., Dyson, H. J., & Wright, P. E.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2018-11-12
- Volume
- 115
- Issue
- 48
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 143
- References
- 5
- Language
- en
- Funders
- HHS | NIH | National Cancer Institute (CA096865)
- HHS | NIH | National Institute of General Medical Sciences (GM075995)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain. https://app.cochat.ai/papers/10.1073/pnas.1814051115
- The paper
- Krois, A. S., Dyson, H. J., & Wright, P. E. (2018). Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1814051115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.